Intelligent Bio Solutions Inc.(INBS)Earnings, Financials & Key RatiosIntelligent Bio Solutions Inc. (INBS) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q3
the company's inability to generate positive free cash flow and its reliance on external funding, evidenced by a $4.5M cash outflow in 2026Q3, present substantial risks to shareholder value.
Intelligent Bio Solutions Inc. (INBS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Intelligent Bio Solutions Inc. (INBS) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 13, 2026 | $1.80vs $1.40-228.6% | $1Mvs $7M-85.3% |
| Q2 2026 | May 12, 2026 | $1.80vs $1.40-228.6% | $1Mvs $7M-85.3% |
| Q1 2026 | Feb 12, 2026 | $2.82vs $0.40-805.0% | $896,774vs $6M-83.7% |
| Q4 2025 | Nov 12, 2025 | $3.50vs $1.50-133.3% | $1Mvs $5M-76.8% |
Recent stock market news and headlines for Intelligent Bio Solutions Inc. (INBS)
Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings
Key metrics vs top competitors for Intelligent Bio Solutions Inc. (INBS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.25 | $1.45M | -0.11 | -1.9% | -346.23% | -192.21% | — | |
| $5.12 | $96.08M | 18.96 | 18.78% | 6.37% | 5.47% | — | |
| $13.79 | $938.85M | -0.83 | -1.89% | -45.57% | -56.31% | — | |
| $25.39 | $66.72M | -3.02 | 195.75% | -59.65% | -98.3% | — | |
| $1.66 | $91.27M | -1.30 | 15.57% | -468.74% | -26.58% | — | |
| $551.50 | $43.8B | 42.16 | 10.42% | 24.63% | 70.87% | — |
Intelligent Bio Solutions Inc. (INBS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Intelligent Bio Solutions Inc. (INBS) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 14, 2026·SEC
Apr 20, 2026·SEC
Mar 23, 2026·SEC
Aug 15, 2025·SEC
Get notified when INBS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Intelligent Bio Solutions Inc. (INBS) stock FAQ — growth, dividends, profitability & financials explained
Intelligent Bio Solutions Inc. (INBS) reported $3.9M in revenue for fiscal year 2025.
Intelligent Bio Solutions Inc. (INBS) saw revenue decline by 1.9% over the past year.
Intelligent Bio Solutions Inc. (INBS) reported a net loss of $11.6M for fiscal year 2025.
Intelligent Bio Solutions Inc. (INBS) has a return on equity (ROE) of -192.2%. Negative ROE indicates the company is unprofitable.
Intelligent Bio Solutions Inc. (INBS) had negative free cash flow of $11.4M in fiscal year 2025, likely due to heavy capital investments.
